Get started
Author

Ying Tian

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
2021 · Stephen Salloway, Spyros Chalkias, et al. · JAMA Neurology · 607
PDF
Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease.
2017 · S Budd Haeberlein, J O'Gorman, et al. · PubMed · 87
Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease
2020 · Samantha Budd Haeberlein, Christian von Hehn, et al. · Alzheimer s & Dementia · 80
PDF
Association of Grandparental and Parental Age at Childbirth With Autism Spectrum Disorder in Children
2020 · Yu Gao, Yongfu Yu, et al. · JAMA Network Open · 52
PDF
Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab
2024 · Tianle Chen, John O'Gorman, et al. · Alzheimer s & Dementia · 33
PDF
Correlation between physical exercise levels, depressive symptoms, and sleep quality in college students: Evidence from electroencephalography
2024 · Zixian Wang, Yu Zhu, et al. · Journal of Affective Disorders · 31
Core outcome set for stable angina pectoris in traditional Chinese medicine (COS-SAP-TCM)
2021 · Mingyan Zhang, Junhua Zhang, et al. · Acupuncture and Herbal Medicine · 18
Disease Modification in Alzheimer’s Disease: Current Thinking
2020 · Hong Liu-Seifert, Jennifer Schumi, et al. · Therapeutic Innovation & Regulatory Science · 18
Baseline Characteristics From ENGAGE and EMERGE: Two Phase 3 Studies to Evaluate Aducanumab in Patients With Early Alzheimer’s Disease (P4.1-001)
2019 · Christian von Hehn, Philipp von Rosenstiel, et al. · Neurology · 15
The relationship between physical activity and diabetes in middle-aged and elderly people
2023 · Ying Tian, Cheng Li, et al. · Medicine · 14
The Relationship between Physical Activity and Depressive Symptoms in Middle-Aged and Elderly People Controlling for Demographic and Health Status Variables
2022 · Yaqun Zhang, Ying Tian · Sustainability · 14
PDF
Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003)
2016 · Vissia Viglietta, John O'Gorman, et al. · Neurology · 13
Toward a National Birth Cohort Study in China
2016 · Jun Zhang, Ying Tian, et al. · American Journal of Public Health · 12
Efficacy and safety of Shugan Jieyu capsule in the treatment of essential hypertension with insomnia, anxiety or depression
2021 · Maoxia Fan, Dong Guo, et al. · Medicine · 11
Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease
2025 · Jeffrey Cummings, Sharon Cohen, et al. · Alzheimer s & Dementia · 10
PDF
A network-based approach to discover diagnostic metabolite markers associated with depressive features for major depressive disorder
2025 · Yuzhen Zheng, Duan Zeng, et al. · Frontiers in Psychiatry · 5
PDF
An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report
2023 · Senmiao Huang, Dianhe Li, et al. · Frontiers in Oncology · 5
Efficacy of dual-task training on motor performance and cognitive function in patients with stroke disease: an umbrella review comprising meta-analyses of randomized controlled trials
2026 · Yezheng Wang, Congcong Li, et al. · BMC Neurology · 2
Efficacy and safety of Yangxue Qingnao granules for the treatment of essential hypertension
2021 · Yongcheng Liu, Dong Guo, et al. · Medicine · 2
Surrogate Endpoints in Drug Development: A Review of Statistical and Regulatory Perspectives and Applications
2025 · Tianle Chen, Ying Tian, et al. · Wiley Interdisciplinary Reviews Computational Statistics · 1
Item‐level analysis of clinical measures in patients with early symptomatic Alzheimer’s disease following treatment with high‐dose aducanumab in the phase 3 study EMERGE
2021 · Sharon Cohen, Ping He, et al. · Alzheimer s & Dementia · 1
PDF
Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease
2021 · Raj Rajagovindan, Tianle Chen, et al. · Alzheimer s & Dementia · 1
Disease Modification in Alzheimer’s Disease: Current Thinking
2019 · Hong Liu-Seifert, Jennifer Schumi, et al. · Therapeutic Innovation & Regulatory Science · 1
Identification and prognostic prediction of high-risk multiple myeloma by exosomal microRNA
2025 · Ying Tian, Wenjiao Tang, et al. · Frontiers in Oncology
PDF
Exploring exercise interventions in substance abuse treatment: A comprehensive bibliometric analysis
2024 · Jiawei Chen, Liu Sun, et al. · Medicine
Works count: 39
Citation count: 1,033
H-index: 12
I10-index: 15
Year
Topic
Type